← SynDRA
RIMCAZOLE
SynDRA canonical compound SYN0000586 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | SIGMAR1 |
| Mechanism of action | Sigma receptor antagonist |
All known targets
Mechanisms of action (all sources)
- Sigma receptor antagonist
- SIGMAR1 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- SCARB1
- DRD2
- ALDH1A1
- GMNN
- TP53
- TDP1
- MAPK1
- KDM4E
- HTT
- HDAC6
- EHMT2
- ALOX15
- DRD3
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- TSHR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT2A
- AHR
- SMAD3
- SMAD2
- RXFP1
- RARA
- PRGR
- PPARD
- NSD2
- KSYK
- KCNH2
- KCMB4
- KCMB2
- KCMB1
- KCMA1
- HTR2C
- HTR2B
- HTR2A
- GLI3
- ESR2
- DRD1
- CP3A7
- CP3A4
- CP2D6
- CP2CJ
- CP2C9
- CP1A2
- CASP7
- CASP3
- ATXN2
- ANDR
- SYK
Drug classes
- Anticonvulsants
- Antipsychotic Agents
- Neuroprotective Agents
Cross-references
Synonyms
- Rimcazol
- BW-234U
- Rimcazolum
- Rimcazole [INN]
- Rimcazol [INN-Spanish]
- Rimcazolum [INN-Latin]
- Cis-9-(3-(3,5-dimethyl-1-piperazinyl)propyl)carbazole
- 9-[3-(Cis-3,5-Dimethyl-1-Piperazinyl)Propyl]Carbazole Hydrochloride
- 9-[3-(cis-3,5-Dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride monohydrate
- 9-[3-[(3R,5S)-3,5-dimethylpiperazin-1-yl]propyl]carbazole
- 9-[3-[(3S,5R)-3,5-dimethylpiperazin-1-yl]propyl]carbazole
- BW 234U
- C3N1PS8CX1
- cis-9-(3-(3,5-dimethyl-1-piperazinyl)propyl)carbazole
- cis-9-[3-(3,5-dimethyl-1-piperazinyl)propyl]carbazole
- RefChem:179466
- DTXCID8028137
- NCGC00025187-01
- UNII-C3N1PS8CX1
- Tocris-1497
- 9-(3-(3,5-dimethylpiperazin-1-yl)propyl)-9H-carbazole
- 9-[3-(3,5-Dimethyl-piperazin-1-yl)-propyl]-9H-carbazole
- SCHEMBL99084
- orb1702878
- 9-[3-[cis-3,5-dimethylpiperazin-1-yl]propyl]carbazole
- SCHEMBL29710924
- CHEBI:94713
- GUDVQJXODNJRIJ-CALCHBBNSA-N
- GLXC-06496
- EX-A5687
- BDBM50019742
- AKOS040746287
- BR177827
- DA-67207
- HY-121813
- CS-0083477
- NS00121747
- T24712
Look up RIMCAZOLE in the interactive SynDRA portal →